Jennifer A. Woyach, MD^1*, Jennifer R. Brown, MD, PhD², Paolo Ghia, MD, PhD³, Lindsey E. Roeker, MD⁴, Krish Patel, MD⁵, Toby A. Eyre^6*, Talha Munir, MBBS, MRCP, FRCPath, PhD^7*, Ewa Lech-Maranda, MD, PhD^8*, Nicole Lamanna, MD⁹, Constantine S. Tam, MD, MBBS^10*, John F. Seymour, MBBS, PhD, FRACP¹¹, Benoit Tessoulin^12*, Nirav N. Shah, MD¹³, Chaitra S Ujjani, MD¹⁴, Bita Fakhri, MD, MPH¹⁵, Catherine C. Coombs, MD¹⁶, Ian W. Flinn, MD, PhD¹⁷, Manish Patel, MD^18*, Sunita D. Nasta, MD¹⁹, Jonathon B. Cohen, MD, MS²⁰, Alvaro J. Alencar, MD²¹, Chan Y. Cheah, MD, DMSc²², Shuo Ma, MD, PhD²³, Joanna M. Rhodes, MD, MSCE^24*, Deepa Jagadeesh, MD²⁵, Pier Luigi Zinzani, MD, PhD²⁶, Anders Osterborg, MD, PhD^27*, Koji Izutsu, MD, PhD²⁸, Donald E. Tsai, MD, PhD^29*, Paolo Abada, MD²⁹, Minna Balbas, PhD^29*, Jian Li, MS^29*, Amy S. Ruppert, PhD^30*, Wojciech Jurczak, MD, PhD³¹ and William G. Wierda, MD, PhD³²

¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
³Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Swedish Cancer Institute, Seattle, WA
⁶Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
⁷Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
⁸Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁹Herbert Irving Comprehensive Cancer Center, Columbia University, New York
¹⁰Alfred Health and Monash University, Melbourne, VIC, Australia
¹¹Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia
¹²Hematology Department, University Hospital, Nantes, France
¹³Medical College of Wisconsin, Milwaukee, WI
¹⁴Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁵Stanford University School of Medicine, Stanford, CA
¹⁶University of California Irvine, Irvine, CA
¹⁷Sarah Cannon Research Institute, Nashville, TN
¹⁸Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
¹⁹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²⁰Winship Cancer Institute, Emory University, Atlanta, GA
²¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²²Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
²³Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
²⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²⁵Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²⁶Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
²⁷Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
²⁸National Cancer Center Hospital, Tokyo, Japan
²⁹Loxo@Lilly, Indianapolis, IN
³⁰Eli Lilly and Company, Indianapolis, IN
³¹Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
³²MD Anderson Cancer Center, Houston, TX

Jennifer R. Brown, MD, PhD¹, Sai Prasad Desikan, MD^2*, Bastien Nguyen, PhD^3*, Helen Won, PhD^3*, Shady I. Tantawy, MD⁴, Samuel McNeely, PhD^5*, Narasimha Marella, Ph.D.^3*, Kevin Ebata, PhD^3*, Jennifer A. Woyach, MD², Krish Patel, MD⁶, Constantine S. Tam, MD, MBBS⁷, Toby A. Eyre^8*, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc⁹, Nirav N. Shah, MD¹⁰, Paolo Ghia, MD, PhD¹¹, Wojciech Jurczak, MD, PhD¹², Minna Balbas, PhD^3*, Binoj Nair, PhD^3*, Paolo Abada, MD³, Chunxiao Wang, Ph.D.^5*, Ying (Denise) Wang, PhD^3*, Lindsey E. Roeker, MD¹³, Varsha Gandhi, PhD¹⁴ and William G. Wierda, MD, PhD⁴

¹Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
²The Ohio State University Comprehensive Cancer Center, Columbus, OH
³Loxo@Lilly, Indianapolis, IN
⁴MD Anderson Cancer Center, Houston, TX
⁵Eli Lilly and Company, Indianapolis, IN
⁶Swedish Cancer Institute, Seattle, WA
⁷Alfred Health and Monash University, East Melbourne, Australia
⁸Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
⁹Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
¹⁰Medical College of Wisconsin, Milwaukee, WI
¹¹Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
¹²Maria Skłodowska – Curie National Research Institute of Oncology, Kraków, Poland
¹³Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX

Constantine S. Tam, MD, MBBS^1,2*, Mary Ann Anderson^3,4*, Masa Lasica^5*, Emma Verner^6,7*, Stephen S. Opat, MBBS, FRACP, FRCPA^8,9, Shuo Ma, MD, PhD¹⁰, Robert Weinkove, MBBS, PhD, FRACP, FRCPA^11,12*, Raul Cordoba, MD, PhD¹³, Jacob Soumerai, MD¹⁴, Paolo Ghia, MD, PhD¹⁵, Sophie Leitch^16*, James Hilger^17*, Yiqian Fang^18*, David Simpson^19*, Haiyi Guo^20* and Chan Yoon Cheah, MD^21,22,23

¹Alfred Hospital, Melbourne, VIC, Australia
²Monash University, Clayton, VIC, Australia
³Division of Blood Cells and Blood Cancer, The Walter and Eliza Hall Institute, Parkville, VIC, Australia
⁴Peter Mac Callum Cancer Centre, Melbourne, VIC, Australia
⁵Department of Haematology, St Vincent’s Hospital Melbourne, Victoria, Australia, Fitzroy, VIC, Australia
⁶Concord Repatriation General Hospital, Concord, NSW, Australia
⁷University of Sydney, Sydney, NSW, Australia
⁸School of Clinical Sciences, Monash University, Melbourne, VIC, Australia
⁹Monash Health, Clayton, VIC, Australia
¹⁰Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
¹¹Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand
¹²Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast & Hutt Valley, Wellington, New Zealand
¹³Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain
¹⁴Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA
¹⁵Universita' Vita-Salute San Raffaele C.F. 97187560152, Milano, MI, Italy
¹⁶Waitematā District Health Board, Auckland, New Zealand
¹⁷BeiGene USA, Inc., San Mateo
¹⁸BeiGene (Shanghai) Co., Ltd., Shanghai, China
¹⁹BeiGene USA, Inc, San Mateo, CA
²⁰BeiGene (Shanghai) Co., Ltd, Shanghai, China
²¹Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
²²Department of Haematology, Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine, Nedlands, Western Australia, Australia
²³Medical School, University of Western Australia, Crawley, Western Australia, Australia

Jennifer A. Woyach, MD¹, Deborah M. Stephens, DO², Danielle M Brander, MD³, Adam S Kittai, MD⁴, Boyu Hu, MD², Andrea Sitlinger, MD^3*, Emily K Curran, MD⁵, Fenlai Tan, MD, PhD⁶, Yi Chen, PhD^7*, Stephen P. Anthony, DO⁷, Yu Chen, MD, PhD⁷ and John C. Byrd, MD⁸

¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
³Duke Cancer Center, Durham, NC
⁴Division of Hematology, The Ohio State University, Columbus, OH
⁵Hematology/Oncology, University of Cincinnati, Cincinnati, OH
⁶Guangzhou Lupeng Pharmaceutical Co. Ltd, Guangzhou, China
⁷Newave Pharmaceutical Inc., Pleasanton, CA
⁸Department of Internal Medicine, University of Cincinnati, Cincinnati, OH

William Townsend, MD, FRCPath, MRCP^1*, Sarah Leong, MBBS^1*, Mittal Shah, PhD^2*, Toby Batten, BSc(HONS), MSc^3*, David Tucker^4*, Bryson Pottinger^5*, Shankaranarayana Paneesha, MD⁶, Dima El-Sharkawi, MBBS, FRCPath, PhD^7*, Toby A. Eyre^8*, Ho Pui Jeff Lam^1*, Jiexin Zheng^9*, Sarah Cook^10*, David Granger, PhD^10*, David Ahern, PhD^11*, Kieran O'Donovan, PhD^10*, Amit C. Nathwani, MD, PhD^9,10 and Parag Jasani, FRCPath, MBBS, MRCP^9*

¹NIHR Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²NovalGen Ltd, London, ENG, United Kingdom
³Veramed, London, Twickenham, United Kingdom
⁴Royal Cornwall Hospital, Cornwall, United Kingdom
⁵Department of Haematology, Royal Cornwall, Hospital, Truro, United Kingdom
⁶Birmingham Heartlands Hospital, Birmingham, United Kingdom
⁷The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
⁸Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom
⁹Royal Free London - NHS Foundation Trust, London, United Kingdom
¹⁰NovalGen Ltd, London, United Kingdom
¹¹Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom

Tanya Siddiqi, MD^1*, David G Maloney, MD, PhD², Saad S. Kenderian, MD³, Danielle M Brander, MD⁴, Kathleen Dorritie, MD⁵, Jacob Soumerai, MD⁶, Peter A Riedell, MD⁷, Nirav N. Shah, MD⁸, Rajneesh Nath^9*, Bita Fakhri, MD, MPH¹⁰, Deborah M. Stephens, DO¹¹, Shuo Ma, MD, PhD¹², Tatyana Feldman, MD^13*, Scott R. Solomon, MD¹⁴, Stephen J. Schuster^15*, Serena K. Perna^16*, Sherilyn A. Tuazon^17*, San-San Ou^17*, Neha Rane^16* and William G. Wierda, MD, PhD¹⁸

¹City of Hope National Medical Center, Duarte, CA
²Fred Hutchinson Cancer Center, Seattle, WA
³Mayo Clinic, Rochester, MN
⁴Duke University Health System, Durham, NC
⁵UPMC Hillman Cancer Center, Pittsburgh, PA
⁶Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
⁷David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
⁸Medical College of Wisconsin, Milwaukee, WI
⁹Banner MD Anderson Cancer Center, Gilbert, AZ
¹⁰University of California San Francisco, San Francisco, CA
¹¹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹²Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
¹³John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ
¹⁴Northside Hospital Cancer Institute, Atlanta, GA
¹⁵Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁶Bristol Myers Squibb, Princeton, NJ
¹⁷Bristol Myers Squibb, Seattle, WA
¹⁸The University of Texas MD Anderson Cancer Center, Houston, TX